Anne E. Jedlicka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anne E. Jedlicka has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Abhai K. Tripathi
Johns Hopkins University
3 shared publications - Amanda Dziedzic
Johns Hopkins University, Baltimore, USA
3 shared publications - Arturo Casadevall
Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University
3 shared publications - Daniel F. Q. Smith
Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University
3 shared publications Godfree Mlambo
Johns Hopkins University, Baltimore, USA
3 shared publicationsBarbara Smith
Johns Hopkins University, Baltimore, USA
2 shared publications
Latest Publications
- 15 November 2026
- Published by Aquatic Mammals Journal in Aquatic Mammals
- Vol. 52 (6) , 526-539
Fungal Colonization of the Nasal Cavities of Stranded Harbor Seal Pups in the Pacific Northwest Region of the United States
Harbor seals (Phoca vitulina) are pinnipeds found in temperate and Arctic marine coastal waters in the Northern Hemisphere. Harbor seal pups are particularly susceptible to stranding due to a combination of biological, environmental, and anthropogenic factors. Infectious disease is a major contributor, often concomitant with malnutrition, and represents a leading cause of pup mortality. In this study, 29 harbor seal pups were opportunistically sampled via nasal swab collection at intake and/or release from rehabilitation, with ten seals having paired samples. Fungal culture and molecular identification were performed. Fungal nasal colonization was identified in 26% (5/19) of seals sampled at intake. Of the five seals with positive fungal culture on intake swabs, four were negative at release and one did not have a release sample collected. The fungal organisms identified were Aureobasidium melanogenum, Rhodotorula mucilaginosa, Sarocladium spp., Candida (Meyerozyma) guilliermondii, and Paradendryphiella arenariae; four of these isolates are documented causes of fungal infections in humans, often in immunocompromised patients. Intrinsic antifungal resistance was documented in two isolates of R. mucilaginosa. A significantly higher proportion of fungal positive samples were collected in May and June, although most seals were sampled in July, and zone was also significantly correlated with fungal positivity. Thus, temporal and geographic factors affect the likelihood of nasal colonization. No aspects of the physical examination served as predictors of fungal colonization. This study contributes new data regarding fungal exposure and colonization in harbor seal pups involved in strandings in the Pacific Northwest. Harbor seals may be susceptible to colonization with opportunistic fungi in the context of stress and immunosuppression.
- 15 November 2026
- Published by Aquatic Mammals Journal in Aquatic Mammals
- Vol. 52 (6) , 526-539
Fungal Colonization of the Nasal Cavities of Stranded Harbor Seal Pups in the Pacific Northwest Region of the United States
Harbor seals (Phoca vitulina) are pinnipeds found in temperate and Arctic marine coastal waters in the Northern Hemisphere. Harbor seal pups are particularly susceptible to stranding due to a combination of biological, environmental, and anthropogenic factors. Infectious disease is a major contributor, often concomitant with malnutrition, and represents a leading cause of pup mortality. In this study, 29 harbor seal pups were opportunistically sampled via nasal swab collection at intake and/or release from rehabilitation, with ten seals having paired samples. Fungal culture and molecular identification were performed. Fungal nasal colonization was identified in 26% (5/19) of seals sampled at intake. Of the five seals with positive fungal culture on intake swabs, four were negative at release and one did not have a release sample collected. The fungal organisms identified were Aureobasidium melanogenum, Rhodotorula mucilaginosa, Sarocladium spp., Candida (Meyerozyma) guilliermondii, and Paradendryphiella arenariae; four of these isolates are documented causes of fungal infections in humans, often in immunocompromised patients. Intrinsic antifungal resistance was documented in two isolates of R. mucilaginosa. A significantly higher proportion of fungal positive samples were collected in May and June, although most seals were sampled in July, and zone was also significantly correlated with fungal positivity. Thus, temporal and geographic factors affect the likelihood of nasal colonization. No aspects of the physical examination served as predictors of fungal colonization. This study contributes new data regarding fungal exposure and colonization in harbor seal pups involved in strandings in the Pacific Northwest. Harbor seals may be susceptible to colonization with opportunistic fungi in the context of stress and immunosuppression.
- Open Access
- 27 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-20
Dietary L-3,4-dihydroxyphenylalanine (L-DOPA) augments cuticular melanization in Anopheles mosquitos reducing their lifespan and malaria burden
L-3,4-dihydroxyphenylalanine (L-DOPA), a naturally occurring tyrosine derivative, is prevalent in environments that include mosquito habitats, potentially serving as part of their diet. Given its role as a precursor for melanin synthesis we investigate the effect of dietary L-DOPA on mosquito physiology and immunity to Plasmodium falciparum and Cryptococcus neoformans infection. Dietary L-DOPA is incorporated into mosquito melanin via a non-canonical pathway and has a profound transcriptional effect associated with enhanced immunity, increased pigmentation, and reduced lifespan. Increased melanization results in an enhanced capacity to absorb electromagnetic radiation that affects mosquito temperatures. Bacteria in the mosquito microbiome act as sources of dopamine, a substrate for melanization. Our results illustrate how an environmentally abundant amino acid analogue can affect mosquito physiology and suggest its potential usefulness as an environmentally friendly vector control agent to reduce malaria transmission, warranting further research and field studies.
- 27 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-20
Open AccessDietary L-3,4-dihydroxyphenylalanine (L-DOPA) augments cuticular melanization in Anopheles mosquitos reducing their lifespan and malaria burden
L-3,4-dihydroxyphenylalanine (L-DOPA), a naturally occurring tyrosine derivative, is prevalent in environments that include mosquito habitats, potentially serving as part of their diet. Given its role as a precursor for melanin synthesis we investigate the effect of dietary L-DOPA on mosquito physiology and immunity to Plasmodium falciparum and Cryptococcus neoformans infection. Dietary L-DOPA is incorporated into mosquito melanin via a non-canonical pathway and has a profound transcriptional effect associated with enhanced immunity, increased pigmentation, and reduced lifespan. Increased melanization results in an enhanced capacity to absorb electromagnetic radiation that affects mosquito temperatures. Bacteria in the mosquito microbiome act as sources of dopamine, a substrate for melanization. Our results illustrate how an environmentally abundant amino acid analogue can affect mosquito physiology and suggest its potential usefulness as an environmentally friendly vector control agent to reduce malaria transmission, warranting further research and field studies.
- Open Access
- 16 October 2024
- Published by Springer Nature in Research Square
Dietary L-3,4-dihydroxyphenylalanine (L-DOPA) augments cuticular melanization in Anopheles mosquitos while reducing their lifespan and malaria parasite burden
L-3,4-dihydroxyphenylalanine (L-DOPA), a naturally occurring tyrosine derivative, is prevalent in environments that include mosquito habitats, potentially serving as part of their diet. Given its role as a precursor for melanin synthesis we investigated the effect of dietary L-DOPA on mosquito physiology and immunity to Plasmodium falciparum and Cryptococcus neoformans infection. Dietary L-DOPA was incorporated into mosquito melanin via a non-canonical pathway and had profound transcriptional effects that were associated with enhanced immunity, increased pigmentation, and reduced lifespan. Increased melanization resulted in an enhanced capacity to absorb electromagnetic radiation that affected mosquito temperatures. Bacteria in the mosquito microbiome were sources of dopamine, which is a substrate for melanization. Our results illustrate how an environmentally abundant amino acid analogue can affect mosquito physiology and suggest its potential usefulness as an environmentally friendly vector control agent to reduce malaria transmission, warranting further research and field studies.
- 16 October 2024
- Published by Springer Nature in Research Square
Open AccessDietary L-3,4-dihydroxyphenylalanine (L-DOPA) augments cuticular melanization in Anopheles mosquitos while reducing their lifespan and malaria parasite burden
L-3,4-dihydroxyphenylalanine (L-DOPA), a naturally occurring tyrosine derivative, is prevalent in environments that include mosquito habitats, potentially serving as part of their diet. Given its role as a precursor for melanin synthesis we investigated the effect of dietary L-DOPA on mosquito physiology and immunity to Plasmodium falciparum and Cryptococcus neoformans infection. Dietary L-DOPA was incorporated into mosquito melanin via a non-canonical pathway and had profound transcriptional effects that were associated with enhanced immunity, increased pigmentation, and reduced lifespan. Increased melanization resulted in an enhanced capacity to absorb electromagnetic radiation that affected mosquito temperatures. Bacteria in the mosquito microbiome were sources of dopamine, which is a substrate for melanization. Our results illustrate how an environmentally abundant amino acid analogue can affect mosquito physiology and suggest its potential usefulness as an environmentally friendly vector control agent to reduce malaria transmission, warranting further research and field studies.
- Open Access
- 12 October 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-9
Clinically relevant atovaquone-resistant human malaria parasites fail to transmit by mosquito
Long-acting injectable medications, such as atovaquone, offer the prospect of a “chemical vaccine” for malaria, combining drug efficacy with vaccine durability. However, selection and transmission of drug-resistant parasites is of concern. Laboratory studies have indicated that atovaquone resistance disadvantages parasites in mosquitoes, but lack of data on clinically relevant Plasmodium falciparum has hampered integration of these variable findings into drug development decisions. Here we generate atovaquone-resistant parasites that differ from wild type parent by only a Y268S mutation in cytochrome b, a modification associated with atovaquone treatment failure in humans. Relative to wild type, Y268S parasites evidence multiple defects, most marked in their development in mosquitoes, whether from Southeast Asia (Anopheles stephensi) or Africa (An. gambiae). Growth of asexual Y268S P. falciparum in human red cells is impaired, but parasite loss in the mosquito is progressive, from reduced gametocyte exflagellation, to smaller number and size of oocysts, and finally to absence of sporozoites. The Y268S mutant fails to transmit from mosquitoes to mice engrafted with human liver cells and erythrocytes. The severe-to-lethal fitness cost of clinically relevant atovaquone resistance to P. falciparum in the mosquito substantially lessens the likelihood of its transmission in the field.
- 12 October 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-9
Open AccessClinically relevant atovaquone-resistant human malaria parasites fail to transmit by mosquito
Long-acting injectable medications, such as atovaquone, offer the prospect of a “chemical vaccine” for malaria, combining drug efficacy with vaccine durability. However, selection and transmission of drug-resistant parasites is of concern. Laboratory studies have indicated that atovaquone resistance disadvantages parasites in mosquitoes, but lack of data on clinically relevant Plasmodium falciparum has hampered integration of these variable findings into drug development decisions. Here we generate atovaquone-resistant parasites that differ from wild type parent by only a Y268S mutation in cytochrome b, a modification associated with atovaquone treatment failure in humans. Relative to wild type, Y268S parasites evidence multiple defects, most marked in their development in mosquitoes, whether from Southeast Asia (Anopheles stephensi) or Africa (An. gambiae). Growth of asexual Y268S P. falciparum in human red cells is impaired, but parasite loss in the mosquito is progressive, from reduced gametocyte exflagellation, to smaller number and size of oocysts, and finally to absence of sporozoites. The Y268S mutant fails to transmit from mosquitoes to mice engrafted with human liver cells and erythrocytes. The severe-to-lethal fitness cost of clinically relevant atovaquone resistance to P. falciparum in the mosquito substantially lessens the likelihood of its transmission in the field.
- Open Access
- 14 February 2020
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 16 (2) , e1008316
A mevalonate bypass system facilitates elucidation of plastid biology in malaria parasites
Malaria parasites rely on a plastid organelle for survival during the blood stages of infection. However, the entire organelle is dispensable as long as the isoprenoid precursor, isopentenyl pyrophosphate (IPP), is supplemented in the culture medium. We engineered parasites to produce isoprenoid precursors from a mevalonate-dependent pathway, creating a parasite line that replicates normally after the loss of the apicoplast organelle. We show that carbon-labeled mevalonate is specifically incorporated into isoprenoid products, opening new avenues for researching this essential class of metabolites in malaria parasites. We also show that essential apicoplast proteins, such as the enzyme target of the drug fosmidomycin, can be deleted in this mevalonate bypass parasite line, providing a new method to determine the roles of other important apicoplast-resident proteins. Several antibacterial drugs kill malaria parasites by targeting basic processes, such as transcription, in the organelle. We used metabolomic and transcriptomic methods to characterize parasite metabolism after azithromycin treatment triggered loss of the apicoplast and found that parasite metabolism and the production of apicoplast proteins is largely unaltered. These results provide insight into the effects of apicoplast-disrupting drugs, several of which have been used to treat malaria infections in humans. Overall, the mevalonate bypass system provides a way to probe essential aspects of apicoplast biology and study the effects of drugs that target apicoplast processes. Malaria parasites rely on an organelle called the apicoplast for growth and survival. Antimalarial drugs such as azithromycin inhibit basic processes in the apicoplast and result in the disruption of the organelle. Surprisingly, addition of a single metabolite, isopentenyl pyrophosphate (IPP), allows the parasites to survive in culture after disruption of the apicoplast. Unfortunately, using IPP to study this phenomenon has several limitations: IPP is prohibitively expensive, has to be used at high concentrations, and has a half-life less than 5 hours. To address these problems, we engineered parasites to express four enzymes from an alternative pathway capable of producing IPP in the parasites. We validated this new system and used it to metabolically label essential metabolites, to delete an essential apicoplast protein, and to characterize the state of apicoplast disrupted parasites. A key finding from these studies comes from transcriptomic and metabolomic analysis of parasites treated with the drug azithromycin. We found that apicoplast disruption results in few changes in parasite metabolism. In particular, the expression of hundreds of nuclear-encoded apicoplast proteins are not affected by disruption of the apicoplast organelle, making it likely that apicoplast metabolic pathways and processes are still functional in apicoplast disrupted parasites.
- 14 February 2020
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 16 (2) , e1008316
Open AccessA mevalonate bypass system facilitates elucidation of plastid biology in malaria parasites
Malaria parasites rely on a plastid organelle for survival during the blood stages of infection. However, the entire organelle is dispensable as long as the isoprenoid precursor, isopentenyl pyrophosphate (IPP), is supplemented in the culture medium. We engineered parasites to produce isoprenoid precursors from a mevalonate-dependent pathway, creating a parasite line that replicates normally after the loss of the apicoplast organelle. We show that carbon-labeled mevalonate is specifically incorporated into isoprenoid products, opening new avenues for researching this essential class of metabolites in malaria parasites. We also show that essential apicoplast proteins, such as the enzyme target of the drug fosmidomycin, can be deleted in this mevalonate bypass parasite line, providing a new method to determine the roles of other important apicoplast-resident proteins. Several antibacterial drugs kill malaria parasites by targeting basic processes, such as transcription, in the organelle. We used metabolomic and transcriptomic methods to characterize parasite metabolism after azithromycin treatment triggered loss of the apicoplast and found that parasite metabolism and the production of apicoplast proteins is largely unaltered. These results provide insight into the effects of apicoplast-disrupting drugs, several of which have been used to treat malaria infections in humans. Overall, the mevalonate bypass system provides a way to probe essential aspects of apicoplast biology and study the effects of drugs that target apicoplast processes. Malaria parasites rely on an organelle called the apicoplast for growth and survival. Antimalarial drugs such as azithromycin inhibit basic processes in the apicoplast and result in the disruption of the organelle. Surprisingly, addition of a single metabolite, isopentenyl pyrophosphate (IPP), allows the parasites to survive in culture after disruption of the apicoplast. Unfortunately, using IPP to study this phenomenon has several limitations: IPP is prohibitively expensive, has to be used at high concentrations, and has a half-life less than 5 hours. To address these problems, we engineered parasites to express four enzymes from an alternative pathway capable of producing IPP in the parasites. We validated this new system and used it to metabolically label essential metabolites, to delete an essential apicoplast protein, and to characterize the state of apicoplast disrupted parasites. A key finding from these studies comes from transcriptomic and metabolomic analysis of parasites treated with the drug azithromycin. We found that apicoplast disruption results in few changes in parasite metabolism. In particular, the expression of hundreds of nuclear-encoded apicoplast proteins are not affected by disruption of the apicoplast organelle, making it likely that apicoplast metabolic pathways and processes are still functional in apicoplast disrupted parasites.
- Open Access
- 2 January 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 11 (473)
A saliva-based rapid test to quantify the infectious subclinical malaria parasite reservoir
A noninvasive malaria rapid test assesses subclinical carriage of Plasmodium falciparum (human malaria) parasites at the point of need.
- 2 January 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 11 (473)
Open AccessA saliva-based rapid test to quantify the infectious subclinical malaria parasite reservoir
A noninvasive malaria rapid test assesses subclinical carriage of Plasmodium falciparum (human malaria) parasites at the point of need.
- 1 January 1994
- Published by S. Karger AG in Cytogenetic and Genome Research
- Vol. 65 (1-2) , 140
Localization of the highly polymorphic locus D19S120 to 19p13.3 by linkage
To obtain the regional localization of a dinucleotide repeat D19S120 (formerly designated LIPE) with 7 alleles and an observed heterozygosity of 73 % (Levitt et al., 1992) we typed 40 CEPH families. Given the high heterozygosity and ease of typing, this marker represents a useful addition to the index map of chromosome 19.
- 1 January 1994
- Published by S. Karger AG in Cytogenetic and Genome Research
- Vol. 65 (1-2) , 140
Localization of the highly polymorphic locus D19S120 to 19p13.3 by linkage
To obtain the regional localization of a dinucleotide repeat D19S120 (formerly designated LIPE) with 7 alleles and an observed heterozygosity of 73 % (Levitt et al., 1992) we typed 40 CEPH families. Given the high heterozygosity and ease of typing, this marker represents a useful addition to the index map of chromosome 19.